Skip Navigation LinksHome > August 2014 - Volume 33 - Issue 8 > Concentration-response Model of Lopinavir/Ritonavir in HIV-1...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0000000000000298
HIV Reports

Concentration-response Model of Lopinavir/Ritonavir in HIV-1–infected Pediatric Patients

Bouazza, Naïm PhD*†; Urien, Saik MD, PhD*†‡; Blanche, Stéphane MD*‡§; Hirt, Déborah PharmD, PhD*†; Foissac, Frantz PhD*†; Benaboud, Sihem PharmD, PhD*†; Tréluyer, Jean-Marc MD, PhD*†‡¶; Frange, Pierre MD

Collapse Box


Objectives: The aims of this study were to analyze the viral load and CD4+ lymphocyte outcomes and the concentration-response of lopinavir/ritonavir (LPV/r) in the treatment of HIV-1–infected antiretroviral-naive children, to determine whether current dosing guidelines for LPV/r achieve Ctrough above 1.0 mg/L for naive patients to compare efficacy of World Health Organization 2010 and Food and Drug Administration dosing recommendations.

Methods: Clinical and biologic examinations were performed before treatment, 1 month, 3 months and then every 3 months in 47 antiretroviral-naive children who started an LPV/r-based regimen. LPV concentrations were also monitored on a routine basis, after 2 weeks of treatment initiation, between 1 and 24 hours after dosing in all children. A population pharmacokinetic-pharmacodynamic analysis was performed using an HIV dynamic model. Simulations of World Health Organization 2010 and Food and Drug Administration dosing recommendations were compared in terms of viral suppression.

Results: The HIV dynamic model adequately described the data. According to the concentration-effect curve, the LPV concentration providing 90% (CLPV90) and 95% (CLPV95) of effect were 1.2 and 2.4 mg/L, respectively. The World Health Organization 2010 guidelines should provide a higher probability of viral success, particularly in infants.

Conclusions: The CLPV90 derived from this model supports current dosing guidelines. However, the target of 2.4 mg/L corresponding to CLPV95 could be used to enhance the efficacy of this drug in treatment-naive children.

© 2014 by Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.